BACKGROUND AND PURPOSE: The Na+/Ca2+ exchanger (NCX) may contribute to triggered activity and transmural dispersion of repolarization, which are substrates of torsades de pointes (TdP) type arrhythmias. This study examined the effects of selective inhibition of the NCX by SEA0400 on the occurrence of dofetilide-induced TdP. EXPERIMENTAL APPROACH: Effects of SEA0400 (1 micromol x L(-1)) on dofetilide-induced TdP was studied in isolated, Langendorff-perfused, atrioventricular (AV)-blocked rabbit hearts. To verify the relevance of the model, lidocaine (30 micromol x L(-1)) and verapamil (750 nmol x L(-1)) were also tested against dofetilide-induced TdP. KEY RESULTS: Acute AV block caused a chaotic idioventricular rhythm and strikingly increased beat-to-beat variability of the RR and QT intervals. SEA0400 exaggerated the dofetilide-induced increase in the heart rate-corrected QT interval (QTc) and did not reduce the incidence of dofetilide-induced TdP [100% in the SEA0400 + dofetilide group vs. 75% in the dofetilide (100 nmol x L(-1)) control]. In the second set of experiments, verapamil further increased the dofetilide-induced QTc prolongation and neither verapamil nor lidocaine reduced the dofetilide-induced increase in the beat-to-beat variability of the QT interval. However, lidocaine decreased and verapamil prevented the development of dofetilide-induced TdP as compared with the dofetilide control (TdP incidence: 13%, 0% and 88% respectively). CONCLUSIONS AND IMPLICATIONS: Na+/Ca2+ exchanger does not contribute to dofetilide-induced TdP, whereas Na+ and Ca2+ channel activity is involved in TdP genesis in isolated, AV-blocked rabbit hearts. Neither QTc prolongation nor an increase in the beat-to-beat variability of the QT interval is a sufficient prerequisite of TdP genesis in rabbit hearts.
BACKGROUND AND PURPOSE: The Na+/Ca2+ exchanger (NCX) may contribute to triggered activity and transmural dispersion of repolarization, which are substrates of torsades de pointes (TdP) type arrhythmias. This study examined the effects of selective inhibition of the NCX by SEA0400 on the occurrence of dofetilide-induced TdP. EXPERIMENTAL APPROACH: Effects of SEA0400 (1 micromol x L(-1)) on dofetilide-induced TdP was studied in isolated, Langendorff-perfused, atrioventricular (AV)-blocked rabbit hearts. To verify the relevance of the model, lidocaine (30 micromol x L(-1)) and verapamil (750 nmol x L(-1)) were also tested against dofetilide-induced TdP. KEY RESULTS: Acute AV block caused a chaotic idioventricular rhythm and strikingly increased beat-to-beat variability of the RR and QT intervals. SEA0400 exaggerated the dofetilide-induced increase in the heart rate-corrected QT interval (QTc) and did not reduce the incidence of dofetilide-induced TdP [100% in the SEA0400 + dofetilide group vs. 75% in the dofetilide (100 nmol x L(-1)) control]. In the second set of experiments, verapamil further increased the dofetilide-induced QTc prolongation and neither verapamil nor lidocaine reduced the dofetilide-induced increase in the beat-to-beat variability of the QT interval. However, lidocaine decreased and verapamil prevented the development of dofetilide-induced TdP as compared with the dofetilide control (TdP incidence: 13%, 0% and 88% respectively). CONCLUSIONS AND IMPLICATIONS: Na+/Ca2+ exchanger does not contribute to dofetilide-induced TdP, whereas Na+ and Ca2+ channel activity is involved in TdP genesis in isolated, AV-blocked rabbit hearts. Neither QTc prolongation nor an increase in the beat-to-beat variability of the QT interval is a sufficient prerequisite of TdP genesis in rabbit hearts.
Authors: Morten B Thomsen; S Cora Verduyn; Milan Stengl; Jet D M Beekman; Geert de Pater; Jurren van Opstal; Paul G A Volders; Marc A Vos Journal: Circulation Date: 2004-10-11 Impact factor: 29.690
Authors: Larissa Fabritz; Paulus Kirchhof; Michael R Franz; Lars Eckardt; Gerold Mönnig; Peter Milberg; Günter Breithardt; Wilhelm Haverkamp Journal: Basic Res Cardiol Date: 2003-02 Impact factor: 17.165
Authors: Annamária Sarusi; Ferenc Rárosi; Mónika Szűcs; Norbert Csík; Attila S Farkas; Julius Gy Papp; András Varró; Tamás Forster; Michael J Curtis; András Farkas Journal: Br J Pharmacol Date: 2014-04 Impact factor: 8.739
Authors: Attila S Farkas; László Rudas; Péter Makra; Norbert Csík; István Leprán; Tamás Forster; Miklós Csanády; Julius Gy Papp; András Varró; András Farkas Journal: Br J Pharmacol Date: 2010-12 Impact factor: 8.739
Authors: James E Tisdale; Heather A Jaynes; Brian R Overholser; Kevin M Sowinski; Richard J Kovacs Journal: J Cardiovasc Electrophysiol Date: 2019-04-21
Authors: Sara Ballouz; Melissa M Mangala; Matthew D Perry; Stewart Heitmann; Jesse A Gillis; Adam P Hill; Jamie I Vandenberg Journal: Cardiovasc Res Date: 2021-08-29 Impact factor: 10.787
Authors: Norbert Nagy; Anita Kormos; Zsófia Kohajda; Áron Szebeni; Judit Szepesi; Piero Pollesello; Jouko Levijoki; Károly Acsai; László Virág; Péter P Nánási; Julius Gy Papp; András Varró; András Tóth Journal: Br J Pharmacol Date: 2014-12 Impact factor: 8.739
Authors: Marta Lemme; Ingke Braren; Maksymilian Prondzynski; Bülent Aksehirlioglu; Bärbel M Ulmer; Mirja L Schulze; Djemail Ismaili; Christian Meyer; Arne Hansen; Torsten Christ; Marc D Lemoine; Thomas Eschenhagen Journal: Cardiovasc Res Date: 2020-07-01 Impact factor: 10.787